Literature DB >> 11313906

Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission.

A Gschwind1, E Zwick, N Prenzel, M Leserer, A Ullrich.   

Abstract

Communication between different cellular signaling systems has emerged as a common principle that enables cells to integrate a multitude of signals from its environment. Transactivation of the epidermal growth factor receptor (EGFR) represents the paradigm for cross-talk between G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs). The recent identification of Zn2+-dependent metalloproteinases and transmembrane growth factor precursors as critical elements in GPCR-induced EGFR transactivation pathways has defined new components of a cellular communication network of rapidly increasing complexity. Further elucidation of the molecular details of the EGFR transactivation mechanism will provide new understanding of its relevance for normal physiological processes and their pathophysiological deviations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313906     DOI: 10.1038/sj.onc.1204192

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  122 in total

1.  Urea signalling to immediate-early gene transcription in renal medullary cells requires transactivation of the epidermal growth factor receptor.

Authors:  Hongyu Zhao; Wei Tian; Hongshi Xu; David M Cohen
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

2.  Long-range signal transmission in autocrine relays.

Authors:  Michal Pribyl; Cyrill B Muratov; Stanislav Y Shvartsman
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

3.  IL-1beta induces expression of matrix metalloproteinase-9 and cell migration via a c-Src-dependent, growth factor receptor transactivation in A549 cells.

Authors:  Ching-Yi Cheng; Chang-Ting Kuo; Chih-Chung Lin; Hsi-Lung Hsieh; Chuen-Mao Yang
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

4.  Lysophosphatidic acid 5 receptor induces activation of Na(+)/H(+) exchanger 3 via apical epidermal growth factor receptor in intestinal epithelial cells.

Authors:  Byong Kwon Yoo; Peijian He; Sei-Jung Lee; C Chris Yun
Journal:  Am J Physiol Cell Physiol       Date:  2011-08-10       Impact factor: 4.249

Review 5.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

6.  Activated human hydroxy-carboxylic acid receptor-3 signals to MAP kinase cascades via the PLC-dependent PKC and MMP-mediated EGFR pathways.

Authors:  Q Zhou; G Li; X Y Deng; X B He; L J Chen; C Wu; Y Shi; K P Wu; L J Mei; J X Lu; N M Zhou
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

7.  Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells.

Authors:  Ingun Heiene Tveteraas; Monica Aasrum; Ingvild Johnsen Brusevold; John Ødegård; Thoralf Christoffersen; Dagny Sandnes
Journal:  Tumour Biol       Date:  2015-09-19

8.  Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression.

Authors:  Victoria Cohen-Kaplan; Ilana Doweck; Inna Naroditsky; Israel Vlodavsky; Neta Ilan
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

9.  Matrix hyaluronan alters epidermal growth factor receptor-dependent cell morphology.

Authors:  Jeanne M V Louderbough; Jose I Lopez; Joyce A Schroeder
Journal:  Cell Adh Migr       Date:  2010-01-29       Impact factor: 3.405

10.  Sustained activity of the EGF receptor is an absolute requisite for LH-induced oocyte maturation and cumulus expansion.

Authors:  Yitzhak Reizel; Judith Elbaz; Nava Dekel
Journal:  Mol Endocrinol       Date:  2009-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.